https://www.selleckchem.com/products/sj6986.html
Recent advances in therapeutic options may prevent deterioration related to Huntington's disease (HD), even at the pre-symptomatic stage. Be that as it may, a well-characterized patient population is essential for screening and monitoring outcome. Accordingly, the aim of this study was to describe the characteristics of a Hungarian subpopulation of HD patients and mutation carriers diagnosed at the University of Szeged. We conducted a search for International Classification of Diseases (ICD) code G10H0 in the local medical database for t
Like
Comment
Share
